Individual investors account for 50% of Corvus Pharmaceuticals, Inc.'s...

Published on 11 Dec 2024 on Simply Wall St. · via Yahoo Finance

Key Insights The considerable ownership by individual investors in Corvus Pharmaceuticals indicates...

Read the rest of the article

Start tracking your investments with Statfolio

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating...

Benzinga · via Yahoo Finance 18 Dec 2024

Key Insights The considerable ownership by individual investors in Corvus Pharmaceuticals indicat...

Simply Wall St. · via Yahoo Finance 11 Dec 2024

Key Insights Significant control over Corvus Pharmaceuticals by retail investors implies that the...

Simply Wall St. · via Yahoo Finance 21 Jun 2024

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shareholders (or potential shareholders) will be happy...

Simply Wall St. via Yahoo Finance 13 May 2024

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript May 6, 2024 Corvus Ph...

Insider Monkey via Yahoo Finance 7 May 2024

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript March 19, 2024 Corvus...

Insider Monkey via Yahoo Finance 22 Mar 2024

Corvus Pharmaceuticals (NASDAQ:CRVS), a biopharmaceutical company focusing on the development of...

Investing.com 21 Mar 2024

Corvus Pharmaceuticals, Inc. CRVS announced that the FDA granted the Orphan Drug Designation to i...

Zacks via Yahoo Finance 12 Feb 2024

Key Insights Corvus Pharmaceuticals' significant individual investors ownership suggests that the...

Simply Wall St. via Yahoo Finance 5 Jan 2024

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 10 Dec 2023